About Us


New Value Creation (Late 2000s ~)

2008 April Long-term goals for environmental preservation was enacted, and Teijin Group Environment-Friendly Design Guidelines were formulated.

Innovation Research Institute (currently Iwakuni R&D Center) was established.

June Acquired majority stake in GH Craft Ltd., a manufacturer with an outstanding record in the design and development of advanced composite materials.
2009 February Teijin Pharma Limited established Esteve Teijin Healthcare S.L.-a joint venture with leading Spanish pharmaceuticals manufacturer Laboratorios del Dr. Esteve S.A.-to oversee HOT business in Europe.
2010 April Transferred stake in P.T. Teijin Indonesia Fiber Tbk to a third party.
2011 March

Developed world's first mass production technology for carbon fiber-reinforced thermoplastics (CFRTP)

May Teijin Pharma Limited commenced sales of hyperuricemia and gout treatment FEBURIC® (TMX-67) in Japan.

Commenced commercial production of high-performance polyethylene products.


Lib separator production joint venture (currently Teijin Lielsort Korea Co., Ltd.) in South Korea was established.

December Teijin Advanced Composites America Inc. was established in the United States.
2012 March Signed an agreement with the China Chemical Fibers Association to enter into a comprehensive alliance.
October Organizational reforms
Teijin Techno Products Limited and industrial fibers business of Teijin Fibers Limited were realigned and integrated into Teijin Limited.
N.I. Teijin Shoji Co., Ltd. and apparel business of Teijin Fibers Limited have been integrated and launched Teijin Frontier Co., Ltd.
2013 April Organizational reforms
Teijin Chemicals Ltd was integrated into Teijin Limited.
May Teijin Composites Innovation Center was moved to the Matsuyama Factory.
September Joint venture Initz Co., Ltd. was established with SK Chemicals Ltd. to start polyphenylene sulfide (PPS) resins business.
2014 April Teijin Product Development China Co., Ltd. was established.
June Joint venture Teijin FRA Tire Cord (Thailand) Co., Ltd. was established to produce tire cords.
2015 April
joint prostheses

Joint venture Teijin Nakashima Medical Co., Ltd., was established to facilitate entry into the market for joint prostheses.

August Technology Development Center was opened in Matsuyama as a development hub for high-performance material solutions.

Started Operation of New R&D Center to accelerate material and pharmaceutical integrated development.

2016 September Teijin Film Solutions Limited was established as a wholly owned subsidiary as a resulf of dissolving of the joint venture arrangement with DuPont Kabushiki Kaisha for Teijin DuPont Films Japan Limited.
2017 January

Acquired Continental Structural Plastics Holdings Corporation, one of the global leaders in automotive lightweight composite technologies.

May Entered into an exclusive worldwide license agreement with Merck & Co., Inc., U.S.A., for the development, manufacture and commercialization of an investigational antibody candidate targeting tau, for a possible new treatment of Alzheimer's disease.
July Teijin Medical Technologies Co., Ltd., was established to expand the bone-connecting material business.
2018 March New carbon-fiber business subsidiary Teijin Carbon Fibers, Inc. was established in the U.S. city of Greenwood, South Carolina, the Unaited States.
Resin compound plant and R&D Facility was established in Teijin Corporation (Thailand) Limited.
April Toho Tenax Co., Ltd. was integrated into Teijin Limited.
August Acquired J.H. Ziegler GmbH, a leading supplier of automotive interior materials in Germany.
Acquired Inapal Plasticos SA, a leading automotive composite supplier in Portugal.
2019 August Acquired Renegade Materials Corporation (Renegade), a leading North American supplier of highly heat-resistant thermoset prepreg for the aerospace industry.
Acquired Benet Automotive s.r.o., a leading automotive composite and component supplier in the Czech Republic.
October Sold entire stake of polyester film businesses in Japan and Indonesia, Teijin Film Solutions Limited and P.T. Indonesia Teijin Film Solutions, to Toyobo Co., Ltd..
2020 February Established Teijin Automotive Center Europe GmbH in Germany as a new base for technical functions in automotive composite business.
April Teijin Home Healthcare Limited changed company name to Teijin Healthcare Limited.
August Agreed alliance to mass produce artificial ligament with Core Tissue BioEngineering.
October Established Teijin Visiting Nurse Station Limited for full-scale development of home-visit nursing care business.
Signed United Nations Global Compact's statement from Business Leaders for Renewed Global Cooperation.
Signed Master Contract with Safran for the purchasing of high performance composite materials.
December Teijin Pharma Limited started exclusive sales of Merz's Xeomin® botulinum toxin type A in Japan.

Continental Structural Plastics Holdings Corporation Established Advanced Technologies Center.

Teijin Pharma Limited and TransThera Biosciences formed strategic R&D collaboration.
Signed comprehensive license agreement with SEMCORP to develop solvent-based coating separator s for LiBs.
2021 January Introduced an internal carbon pricing system for capital investment plans.
February Committed to Science Based Targets within two years to reduce greenhouse gas emissions.